{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T16:28:38Z","timestamp":1744734518891},"reference-count":20,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021,11,8]]},"DOI":"10.7759\/cureus.19367","type":"journal-article","created":{"date-parts":[[2021,11,8]],"date-time":"2021-11-08T17:24:33Z","timestamp":1636392273000},"source":"Crossref","is-referenced-by-count":2,"title":["Bradyarrhythmia in COVID-19 Patients"],"prefix":"10.7759","author":[{"given":"Abdulrahman","family":"Hakami","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aisha","family":"Moafa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abeer","family":"Alomaish","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryam","family":"Mashraqi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1128\/CMR.00023-07","article-title":"Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection","volume":"20","author":"Cheng VC","year":"2007","unstructured":"Cheng VC, Lau SK, Woo PC, Yuen KY. Severe acute respiratory syndrome coronavirus as an agent of emerging and reemerging infection. Clin Microbiol Rev. 2007, 20:660-94. 10.1128\/CMR.00023-07","journal-title":"Clin Microbiol Rev"},{"key":"ref2","article-title":"Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou","volume":"13","author":"Zhang SF","year":"2018","unstructured":"Zhang SF, Tuo JL, Huang XB, et al.. Epidemiology characteristics of human coronaviruses in patients with respiratory infection symptoms and phylogenetic analysis of HCoV-OC43 during 2010-2015 in Guangzhou. PLoS One. 2018, 13:e0191789.","journal-title":"PLoS One"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25678","article-title":"Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle","volume":"92","author":"Lu H","year":"2020","unstructured":"Lu H, Stratton CW, Tang YW. Outbreak of pneumonia of unknown etiology in Wuhan, China: the mystery and the miracle. J Med Virol. 2020, 92:401-2. 10.1002\/jmv.25678","journal-title":"J Med Virol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1186\/s40779-020-00240-0","article-title":"The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status","volume":"7","author":"Guo YR","year":"2020","unstructured":"Guo YR, Cao QD, Hong ZS, et al.. The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status. Mil Med Res. 2020, 7:11. 10.1186\/s40779-020-00240-0","journal-title":"Mil Med Res"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1016\/j.jacc.2020.03.031","article-title":"Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic","volume":"75","author":"Driggin E","year":"2020","unstructured":"Driggin E, Madhavan MV, Bikdeli B, et al.. Cardiovascular considerations for patients, health care workers, and health systems during the COVID-19 pandemic. J Am Coll Cardiol. 2020, 75:2352-71. 10.1016\/j.jacc.2020.03.031","journal-title":"J Am Coll Cardiol"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2020-0702","article-title":"Epidemiology of COVID-19 among children in China","volume":"145","author":"Dong Y","year":"2020","unstructured":"Dong Y, Mo X, Hu Y, Qi X, Jiang F, Jiang Z, Tong S. Epidemiology of COVID-19 among children in China. Pediatrics. 2020, 145:e20200702. 10.1542\/peds.2020-0702","journal-title":"Pediatrics"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1016\/j.cjca.2020.03.028","article-title":"Characteristic electrocardiographic manifestations in patients with COVID-19","volume":"36","author":"He J","year":"2020","unstructured":"He J, Wu B, Chen Y, et al.. Characteristic electrocardiographic manifestations in patients with COVID-19. Can J Cardiol. 2020, 36:966.e1-4. 10.1016\/j.cjca.2020.03.028","journal-title":"Can J Cardiol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li B","year":"2020","unstructured":"Li B, Yang J, Zhao F, et al.. Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China. Clin Res Cardiol. 2020, 109:531-8. 10.1007\/s00392-020-01626-9","journal-title":"Clin Res Cardiol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South AM","year":"2020","unstructured":"South AM, Diz DI, Chappell MC. COVID-19, ACE2, and the cardiovascular consequences. Am J Physiol Heart Circ Physiol. 2020, 318:H1084-90. 10.1152\/ajpheart.00217.2020","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.120.046941","article-title":"COVID-19 and cardiovascular disease","volume":"141","author":"Clerkin KJ","year":"2020","unstructured":"Clerkin KJ, Fried JA, Raikhelkar J, et al.. COVID-19 and cardiovascular disease. Circulation. 2020, 141:1648-55. 10.1161\/CIRCULATIONAHA.120.046941","journal-title":"Circulation"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1001\/jamacardio.2020.1286","article-title":"Potential effects of coronaviruses on the cardiovascular system. A review","volume":"5","author":"Madjid M","year":"2020","unstructured":"Madjid M, Safavi-Naeini P, Solomon SD, Vardeny O. Potential effects of coronaviruses on the cardiovascular system. A review. JAMA Cardiol. 2020, 5:831-40. 10.1001\/jamacardio.2020.1286","journal-title":"JAMA Cardiol"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1001\/jama.2020.2648","article-title":"Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention","volume":"323","author":"Wu Z","year":"2020","unstructured":"Wu Z, McGoogan JM. Characteristics of and important lessons from the coronavirus disease 2019 (COVID-19) outbreak in China. Summary of a report of 72 314 cases from the Chinese Center for Disease Control and Prevention. JAMA. 2020, 323:1239-42. 10.1001\/jama.2020.2648","journal-title":"JAMA"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1086\/426029","article-title":"Use of simple laboratory features to distinguish the early stage of severe acute respiratory syndrome from dengue fever","volume":"39","author":"Wilder-Smith A","year":"2004","unstructured":"Wilder-Smith A, Earnest A, Paton NI. Use of simple laboratory features to distinguish the early stage of severe acute respiratory syndrome from dengue fever. Clin Infect Dis. 2004, 39:1818-23. 10.1086\/426029","journal-title":"Clin Infect Dis"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.1002\/clc.23384","article-title":"Cardiovascular manifestations in severe and critical patients with COVID-19","volume":"43","author":"Chen Q","year":"2020","unstructured":"Chen Q, Xu L, Dai Y, et al.. Cardiovascular manifestations in severe and critical patients with COVID-19. Clin Cardiol. 2020, 43:796-802. 10.1002\/clc.23384","journal-title":"Clin Cardiol"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-020-05991-x","article-title":"Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China","volume":"46","author":"Ruan Q","year":"2020","unstructured":"Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020, 46:846-8. 10.1007\/s00134-020-05991-x","journal-title":"Intensive Care Med"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1186\/s12879-016-1492-4","article-title":"Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia","volume":"16","author":"Al Ghamdi M","year":"2016","unstructured":"Al Ghamdi M, Alghamdi KM, Ghandoora Y, et al.. Treatment outcomes for patients with Middle Eastern Respiratory Syndrome Coronavirus (MERS CoV) infection at a coronavirus referral center in the Kingdom of Saudi Arabia. BMC Infect Dis. 2016, 16:174. 10.1186\/s12879-016-1492-4","journal-title":"BMC Infect Dis"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.3201\/eid1005.030640","article-title":"Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients","volume":"10","author":"Wang JT","year":"2004","unstructured":"Wang JT, Sheng WH, Fang CT, et al.. Clinical manifestations, laboratory findings, and treatment outcomes of SARS patients. Emerg Infect Dis. 2004, 10:818-24. 10.3201\/eid1005.030640","journal-title":"Emerg Infect Dis"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1093\/infdis\/jiaa119","article-title":"Clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in Shenzhen, China","volume":"221","author":"Wang Y","year":"2020","unstructured":"Wang Y, Liu Y, Liu L, Wang X, Luo N, Li L. Clinical outcomes in 55 patients with severe acute respiratory syndrome coronavirus 2 who were asymptomatic at hospital admission in Shenzhen, China. J Infect Dis. 2020, 221:1770-4. 10.1093\/infdis\/jiaa119","journal-title":"J Infect Dis"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1002\/jmv.25770","article-title":"Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19","volume":"92","author":"Gao Y","year":"2020","unstructured":"Gao Y, Li T, Han M, et al.. Diagnostic utility of clinical laboratory data determinations for patients with the severe COVID-19. J Med Virol. 2020, 92:791-6. 10.1002\/jmv.25770","journal-title":"J Med Virol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.1016\/j.hrthm.2020.03.028","article-title":"Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association","volume":"17","author":"Lakkireddy DR","year":"2020","unstructured":"Lakkireddy DR, Chung MK, Gopinathannair R, et al.. Guidance for cardiac electrophysiology during the COVID-19 pandemic from the Heart Rhythm Society COVID-19 Task Force; Electrophysiology Section of the American College of Cardiology; and the Electrocardiography and Arrhythmias Committee of the Council on Clinical Cardiology, American Heart Association. Heart Rhythm. 2020, 17:e233-41. 10.1016\/j.hrthm.2020.03.028","journal-title":"Heart Rhythm"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/72248-bradyarrhythmia-in-covid-19-patients","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,9]],"date-time":"2024-02-09T19:33:15Z","timestamp":1707507195000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/72248-bradyarrhythmia-in-covid-19-patients"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11,8]]},"references-count":20,"URL":"https:\/\/doi.org\/10.7759\/cureus.19367","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11,8]]}}}